| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,085 |
1,603 |
$71K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,557 |
1,274 |
$33K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
150 |
127 |
$13K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
352 |
287 |
$12K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
76 |
74 |
$3K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
217 |
178 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
111 |
82 |
$2K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
65 |
57 |
$1K |
| 71046 |
Radiologic examination, chest; 2 views |
124 |
86 |
$902.42 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
137 |
105 |
$616.49 |
| 99201 |
|
13 |
12 |
$224.55 |
| 80061 |
Lipid panel |
30 |
26 |
$199.76 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
32 |
32 |
$153.93 |
| 1159F |
|
285 |
233 |
$0.00 |
| 1160F |
|
285 |
233 |
$0.00 |
| 3078F |
|
167 |
134 |
$0.00 |
| 81003 |
|
21 |
12 |
$0.00 |
| 3725F |
|
15 |
12 |
$0.00 |
| 1126F |
|
235 |
187 |
$0.00 |
| 1125F |
|
147 |
115 |
$0.00 |
| 3008F |
|
420 |
341 |
$0.00 |
| 3074F |
|
224 |
179 |
$0.00 |
| 1036F |
|
416 |
297 |
$0.00 |
| 3079F |
|
12 |
12 |
$0.00 |